The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Radioiodine Therapy for Hyperthyroidism
Abstract
A 37-year-old woman receives a diagnosis of Graves' disease and is treated with methimazole for 1 year. After completing this treatment, she presents with recurrent symptoms of hyperthyroidism. Radioiodine ablation is recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Molecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384
Cooper, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra042972 · Cited by 1,008
Life-Threatening Thyrotoxicosis: Thyroid Storm
Burch, H. B., & Wartofsky, L. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30165-8 · Cited by 852
Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy
Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715
THE EPIDEMIOLOGY OF THYROID DISEASE AND IMPLICATIONS FOR SCREENING
Wang, C., & Crapo, L. M. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70240-1 · Cited by 525
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Cancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
WARTOFSKY, L., GLINOER, D., SOLOMON, B., NAGATAKI, S., LAGASSE, R., NAGAYAMA, Y., & IZUMI, M. (1991) · Thyroid · doi:10.1089/thy.1991.1.129 · Cited by 374
LAURBERG, P., PEDERSEN, K. M., VESTERGAARD, H., & SIGURDSSON, G. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00368.x · Cited by 361
Bartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A., & Pinchera, A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212001 · Cited by 318
Torring, O. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2986 · Cited by 311
Mortality after the Treatment of Hyperthyroidism with Radioactive Iodine
Franklyn, J. A., Maisonneuve, P., Sheppard, M. C., Betteridge, J., & Boyle, P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381103 · Cited by 309
Träisk, F., Tallstedt, L., Abraham-Nordling, M., Andersson, T., Berg, G., Calissendorff, J., Hallengren, B., Hedner, P., Lantz, M., Nyström, E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0747 · Cited by 262
Thyroid–Adrenergic Interactions: Physiological and Clinical Implications
Silva, J. E., & Bianco, S. D. C. (2008) · Thyroid · doi:10.1089/thy.2007.0252 · Cited by 252
High Dose 131I Therapy for the Treatment of Hyperthyroidism Caused by Graves' Disease
Alexander, E. K. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1073 · Cited by 251
Franklyn, J. A., Maisonneuve, P., Sheppard, M., Betteridge, J., & Boyle, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12295-x · Cited by 243
Parma, J., Duprez, L., Van Sande, J., Hermans, J., Rocmans, P., Van Vliet, G., Costagliola, S., Rodien, P., Dumont, J. E., & Vassart, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4144 · Cited by 235
Read, C. H., Tansey, M. J., & Menda, Y. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031223 · Cited by 204
Walter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' Disease
Sridama, V., McCormick, M., Kaplan, E. L., Fauchet, R., & DeGroot, L. J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408163110702 · Cited by 190
PETERS, H., FISCHER, C., BOGNER, U., REINERS, C., & SCHLEUSENER, H. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01547.x · Cited by 174
Abraham-Nordling, M., Törring, O., Hamberger, B., Lundell, G., Tallstedt, L., Calissendorff, J., & Wallin, G. (2005) · Thyroid · doi:10.1089/thy.2005.15.1279 · Cited by 163
Increased cancer incidence after radioiodine treatment for hyperthyroidism
Metso, S., Auvinen, A. P., Huhtala, H., Salmi, J., Oksala, H., & Jaatinen, P. (2007) · Cancer · doi:10.1002/cncr.22635 · Cited by 161
Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
Jarløv, A. E., Hegedüst, L., Kristensen, L. Ø., Nygaard, B., & Hansen, J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02039.x · Cited by 155
Hyperthyroidism, Thyroid Hormone Therapy, and Bone
Ross, D. S. (1994) · Thyroid · doi:10.1089/thy.1994.4.319 · Cited by 150
Self-citationNygaard, B., Hegedüs, L., Gerhard Nielsen, K., Ulriksen, P., & Hansen, J. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00635.x · Cited by 148
Imseis, R. E., VanMiddlesworth, L., MASSIE, J. D., Bush, A. J., & Vanmiddlesworth, N. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4538 · Cited by 147
Lai, A., Sassi, L., Compri, E., Marino, F., Sivelli, P., Piantanida, E., Tanda, M. L., & Bartalena, L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2130 · Cited by 129
Radioiodine Therapy for Multinodular Toxic Goiter
Nygaard, B., Hegedüs, L., Ulriksen, P., Nielsen, K. G., & Hansen, J. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.12.1364 · Cited by 120
Ceccarelli, C., Bencivelli, W., Vitti, P., Grasso, L., & Pinchera, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02218.x · Cited by 109
Follow-up of Solitary Autonomous Thyroid Nodules Treated with 131I
Goldstein, R., & Hart, I. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312153092401 · Cited by 104
Ljunggren, J., Törring, O., Wallin, G., Taube, A., Tallstedt, L., Hamberger, B., & Lundell, G. E. F. (1998) · Thyroid · doi:10.1089/thy.1998.8.653 · Cited by 101
Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism.
Holm, L., Lundell, G. E. F., Israelsson, A., & Dahlqvist, I. (1982) · PubMed · Cited by 100
Thyrotoxicosis in the very old
Tibaldi, J. M., Barzel, U. S., Albin, J., & Surks, M. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90547-4 · Cited by 91
Ross, D. S., Ridgway, E. C., & DANIELS, G. H. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-488 · Cited by 90
Self-citationHolst, J. P., Burman, K. D., Atkins, F., Umans, J. G., & Jonklaas, J. (2005) · Thyroid · doi:10.1089/thy.2005.15.1321 · Cited by 86
Transition of Nodular Toxic Goiter to Autoimmune Hyperthyroidism Triggered by 131I Therapy
NYGAARD, B., FABER, J., VEJE, A., HEGEDÜS, L., & HANSEN, J. M. (1999) · Thyroid · doi:10.1089/thy.1999.9.477 · Cited by 84
Treatment Options for Graves Disease: A Cost-Effectiveness Analysis
In, H., Pearce, E. N., Wong, A. K. G., Burgess, J. F., McAneny, D. B., & Rosen, J. E. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.03.025 · Cited by 81
CODACCIONI, J. L., ORGIAZZI, J., BLANC, P., PUGEAT, M., ROULIER, R., & CARAYON, P. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-656 · Cited by 76
Evidence‐based Management of Toxic Multinodular Goiter (Plummer’s Disease)
Porterfield, J. R., Thompson, G. B., Farley, D. R., Grant, C. S., & Richards, M. L. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9566-0 · Cited by 76
Uy, H. L., Reasner, C. A., & Samuels, M. H. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80137-5 · Cited by 75
FUNCTIONAL AND HISTOLOGIC EFFECTS OF THERAPEUTIC DOSES OF RADIOACTIVE IODINE ON THE THYROID OF MAN*
DOBYNS, B. M., Vickery, A. L., Maloof, F., & Chapman, E. M. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-5-548 · Cited by 73
Kubota, S., Ohye, H., Genichiro, Y. A. N. O., Nishihara, E., Kudo, T., Ito, M., Fukata, S., Amino, N., Kuma, K., & Miyauchi, A. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-057 · Cited by 27
Cited by
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Bonnema, S. J., & Hegedüs, L. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 339
Management of Graves Disease: A Review
Burch, H. B., & Cooper, D. S. (2015) · JAMA · doi:10.1001/jama.2015.16535 · Cited by 332
Lee, S. L. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328357fa0c · Cited by 307
Diagnosis and management of Graves disease: a global overview
Bartalena, L. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.193 · Cited by 296
Metadata
- Authors
- Ross, D. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-02-10
- Volume
- 364
- Issue
- 6
- Pages
- 542-550
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2099373769
- Cited by
- 284
- References
- 46
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.